Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build...
Up To Date
Latest News
BioInvent has successfully carried out a directed share issue of approximately SEK 300 million (approximately...
Immunocore sells around 3.7m shares in a private placement with a 20% discount and gets USD140m to advance its...
European Medicines Agency (EMA) has accepted the application for biosimilar natalizumab, a proposed...
Agomab Therapeutics NV from Ghent, Belgium, today announced it has extended its Series B financing round with...